InvestorsHub Logo
Post# of 251562
Next 10
Followers 253
Posts 17890
Boards Moderated 0
Alias Born 01/19/2006

Re: None

Thursday, 10/20/2016 4:10:13 PM

Thursday, October 20, 2016 4:10:13 PM

Post# of 251562
ALKS: Alkermes Announces Positive Topline Results From FORWARD-5 Pivotal Phase 3 Study of ALKS 5461 for Major Depressive Disorder

+ 40% AH

http://www.businesswire.com/news/home/20161020006475/en/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.